Angiogenesis


During tumor angiogenesis, cancer cells stimulate formation of new blood vessel for delivering oxygen and nutrients to a tumor. As the tumor grows, cells at the center of the mass become starved of oxygen, causing hypoxia. It stabilizes the expression of a transcription factor, HIF-1α (hypoxia inducible factor-1), which binds HIF-1β to upregulate the expression of several angiogenesis-promoting genes. Moreover, growth factor signaling also stimulates HIF-1 activity in order to maintain oxygen homeostasis for growing cells.
-
A4189 IOX2(Glycine)1 CitationSummary: HIF-1α prolyl hydroxylase-2 (PHD2) inhibitor -
B6664 GR 144053 trihydrochlorideSummary: platelet fibrinogen receptor glycoprotein IIb/IIIa (GpIIb/IIIa) antagonist -
B6764 Combretastatin A4Summary: tubulin polymerization inhibitor -
B2298 Plinabulin (NPI-2358)Target: Vascular Disrupting Agents (VDA)Summary: vascular disrupting agent -
B1115 BAY 87-2243Target: Hypoxia Inducible Factors (HIFs)Summary: HIF-1 inhibitor,potent and selective -
A4507 KC7F25 CitationSummary: HIF-1α inhibitor -
A4509 PX 121 CitationTarget: TrxSummary: Trx-1 inhibitor -
A4506 DMOG5 CitationTarget: Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs)Summary: Competitive HIF-PH inhibitor, cell-permeable -
B5391 Echistatin, α1 isoformSummary: Potent irreversible αVβ3 integrin antagonist -
B5644 LDV FITCSummary: fluorescent ligand that binds to the α4β1 integrin (VLA-4)

